#15 Clinical Context
Background information relevant to the evolving cannabis medicine landscape.
The new total THC standard closes the loophole that allowed many popular hemp products to exist, meaning THCA flower and similar products will be treated as illegal marijuana.
The 2026 Farm Bill draft replaces the 2018 Farm Bill’s delta-9-only threshold with a total THC metric capturing THCA-rich products that decarboxylate into intoxicating THC. Farmers can self-designate as ‘only industrial hemp,’ which eliminates the 10-year felony ineligibility period. But those who violate the designation face a 5-year ban. Democratic leadership has already taken issue with the proposal. The HEMP Act remains the best legislative alternative for cannabinoid businesses.
“Switching from delta-9 to total THC is the single most consequential regulatory change in hemp history,it redefines what hemp IS and eliminates the legal basis for an entire market overnight.”
WHAT I’M WATCHING THIS WEEK IN CANNABINOIDS
Five things on my radar:
1. FDA SILENCE POST-DEADLINE. The Feb 10 deadline passed with no cannabinoid classification lists published. Every day without FDA action is another day of uncertainty. Watch for whether the agency issues any guidance, even informal, in the coming weeks.
2. OREGON’S HB 4139. The 17% hemp cannabinoid tax bill is moving through committee. If it passes, it becomes a model for other states considering how to regulate (and tax) hemp products pre-November.
3. HEMP ACT MOMENTUM. The bipartisan bill introduced Feb 2 needs co-sponsors. The next two weeks will tell us whether this has legs or is symbolic. Track the co-sponsor count.
4. STATE ENFORCEMENT POSTURE. Several states are signaling how they’ll handle the transition. Colorado, Vermont, and California have been notably quiet. States with existing hemp regulatory frameworks may choose to continue enforcing their own rules regardless of federal changes.
5. BANKING MOVES. Watch for payment processor announcements. If major platforms (Stripe, Square, PayPal) issue formal policy updates on hemp CBD, it signals the financial industry is preparing for the ban to take effect as written.
Bottom line: February 2026 is a month of signals. The FDA’s silence, state legislative activity, and Congressional response to the HEMP Act will collectively determine whether the industry has a path forwardโor is heading into November blind.
Have thoughts on this? Share it:
๐ฌ Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan โ
Want to discuss this topic with other patients and caregivers? Join the forum discussion โ